Treatment and long-term follow-up of pediatric patients with hypocomplementemic urticarial vasculitis syndrome (HUVS): a case-based review

Özen Taş, Aydın F, Özçakar ZB

Clin Rheumatol · 2025

Grade Ccase series

Key Findings

  • Long-term follow-up of two DNASE1L3-mutant siblings over 20 years
  • Rituximab most effective long-term treatment
  • Renal involvement in 82% of pediatric HUVS patients
  • Lupus nephritis most common renal manifestation

Referenced in (1 disease)

ID: pmid-40455313DOI: 10.1007/s10067-025-07509-6PMID: 40455313